Prevalence of and recent developments in female sexual dysfunction.
In the past few years, female sexual dysfunction (FSD) has attracted significant attention. The main reason for this was the successful introduction of oral pharmacotherapy for the treatment of male erectile dysfunction. This raised the question of whether a vascular medication such as sildenafil would be efficacious for female sexual dysfunction. Once triggered, female sexual dysfunction research went even further and raised more questions. This article addresses the prevalence of FSD and the most recent developments in this field.
Shabsigh
R
R
Department of Urology, Columbia-Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA. rs 66@columbia.edu
D000328:Adult; D005260:Female; D006304:Health Status; D006801:Humans; D008593:Menopause / Q000502:physiology; D008875:Middle Aged; D015995:Prevalence; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D011795:Surveys and Questionnaires